Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO28276 | Artemisia argyi | Species | Asteraceae | Eukaryota | TM-MC* | |||
NPO10492 | Artemisia montana | Species | Asteraceae | Eukaryota | TM-MC* | |||
NPO25094 | Artemisia princeps | Species | Asteraceae | Eukaryota | TM-MC* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | ED50 | = | 7.08 | mg/kg | 15013005 |
NPT324 | Individual Protein | Cyclooxygenase-1 | Ovis aries | IC50 | = | 2260 | nM | 15013005 |
NPT325 | Individual Protein | Cyclooxygenase-2 | Ovis aries | IC50 | = | 265500 | nM | 15013005 |
NPT3781 | Protein Family | Interleukin-8 receptors, CXCR1/CXCR2 | Homo sapiens | Inhibition | = | 34 | % | 15974585 |
NPT3782 | Protein Family | Prostaglandin G/H synthase (cyclooxygenase) | Mus musculus | Inhibition | > | 99 | % | 15974585 |
NPT3781 | Protein Family | Interleukin-8 receptors, CXCR1/CXCR2 | Homo sapiens | IC50 | = | 100 | nM | 15974585 |
NPT2749 | Individual Protein | Acetylcholinesterase | Rattus norvegicus | Inhibition | = | 20 | % | 17126019 |
NPT139 | Cell Line | HT-29 | Homo sapiens | IC50 | > | 1000000 | nM | 17110105 |
NPT83 | Cell Line | MCF7 | Homo sapiens | IC50 | = | 795000 | nM | 17110105 |
NPT30 | Individual Protein | Cyclooxygenase-1 | Homo sapiens | Inhibition | = | 90 | % | 17110105 |
NPT30 | Individual Protein | Cyclooxygenase-1 | Homo sapiens | Inhibition | = | 29 | % | 17110105 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 55.64 | % | 17481895 |
NPT30 | Individual Protein | Cyclooxygenase-1 | Homo sapiens | IC50 | = | 2600 | nM | 18457385 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Inhibition | = | 23.9 | % | 20804197 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Inhibition | = | 30.3 | % | 20804197 |
NPT2 | Others | Unspecified | Ratio IC50 | = | 2.1 | 20804197 | ||
NPT325 | Individual Protein | Cyclooxygenase-2 | Ovis aries | IC50 | = | 1500 | nM | 20804197 |
NPT324 | Individual Protein | Cyclooxygenase-1 | Ovis aries | IC50 | = | 3200 | nM | 20804197 |
NPT483 | Individual Protein | Prelamin-A/C | Homo sapiens | Potency | = | 2511.9 | nM | PubChem BioAssay data set |
NPT312 | Organism | Saccharomyces cerevisiae | Saccharomyces cerevisiae | Potency | = | 14581 | nM | PubChem BioAssay data set |
NPT210 | Individual Protein | Thyroid stimulating hormone receptor | Homo sapiens | Potency | = | 2511.9 | nM | PubChem BioAssay data set |
NPT794 | Individual Protein | Endonuclease 4 | Escherichia coli K-12 | Potency | = | 251.2 | nM | PubChem BioAssay data set |
NPT796 | Individual Protein | Peripheral myelin protein 22 | Homo sapiens | Potency | = | 84921.4 | nM | PubChem BioAssay data set |
NPT54 | Individual Protein | Nonstructural protein 1 | Influenza A virus | Potency | = | 22387.2 | nM | PubChem BioAssay data set |
NPT58 | Individual Protein | Bloom syndrome protein | Homo sapiens | Potency | = | 2.8 | nM | PubChem BioAssay data set |
NPT212 | Individual Protein | Cytochrome P450 2C9 | Homo sapiens | Potency | = | 31622.8 | nM | PubChem BioAssay data set |
NPT212 | Individual Protein | Cytochrome P450 2C9 | Homo sapiens | Potency | = | 15848.9 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | Potency | = | 35481.3 | nM | PubChem BioAssay data set | |
NPT212 | Individual Protein | Cytochrome P450 2C9 | Homo sapiens | Potency | = | 39810.7 | nM | PubChem BioAssay data set |
NPT5 | Individual Protein | Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 | Homo sapiens | Potency | 0.7 | nM | PubChem BioAssay data set | |
NPT62 | Individual Protein | 6-phospho-1-fructokinase | Trypanosoma brucei | Potency | 1901.2 | nM | PubChem BioAssay data set | |
NPT533 | Protein-Protein Interaction | Runt-related transcription factor 1/Core-binding factor subunit beta | Homo sapiens | Potency | 7943.3 | nM | PubChem BioAssay data set | |
NPT212 | Individual Protein | Cytochrome P450 2C9 | Homo sapiens | AC50 | = | 39810.72 | nM | PubChem BioAssay data set |
NPT212 | Individual Protein | Cytochrome P450 2C9 | Homo sapiens | AC50 | = | 15848.93 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | Ki | = | 44.4 | nM | 21802289 | |
NPT135 | Individual Protein | Chromobox protein homolog 1 | Homo sapiens | Potency | 79432.8 | nM | PubChem BioAssay data set | |
NPT698 | Individual Protein | Regulator of G-protein signaling 4 | Homo sapiens | Potency | 946.6 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 3662.6 | nM | PubChem BioAssay data set | ||
NPT694 | Individual Protein | UDP-glucuronosyltransferase 1-3 | Homo sapiens | Activity | = | 83 | pm/min/mg | 10836148 |
NPT30 | Individual Protein | Cyclooxygenase-1 | Homo sapiens | IC50 | = | 105 | nM | DrugMatrix in vitro pharmacology data |
NPT30 | Individual Protein | Cyclooxygenase-1 | Homo sapiens | IC50 | = | 98.65 | nM | 21602044 |
NPT31 | Individual Protein | Cyclooxygenase-2 | Homo sapiens | IC50 | = | 730 | nM | 21602044 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Inhibition | = | 29.5 | % | 21602044 |
NPT32 | Organism | Mus musculus | Mus musculus | Inhibition | = | 68.7 | % | 21602044 |
NPT324 | Individual Protein | Cyclooxygenase-1 | Ovis aries | IC50 | = | 1480 | nM | 21602044 |
NPT2 | Others | Unspecified | Potency | 10000 | nM | PubChem BioAssay data set | ||
NPT3507 | Individual Protein | Aldo-keto reductase family 1 member C2 | Homo sapiens | IC50 | = | 42400 | nM | 22877157 |
NPT3504 | Individual Protein | Aldo-keto-reductase family 1 member C3 | Homo sapiens | IC50 | = | 32700 | nM | 22877157 |
NPT3506 | Individual Protein | Aldo-keto reductase family 1 member C4 | Homo sapiens | IC50 | > | 100000 | nM | 22877157 |
NPT3505 | Individual Protein | Aldo-keto reductase family 1 member C1 | Homo sapiens | IC50 | > | 100000 | nM | 22877157 |
NPT32 | Organism | Mus musculus | Mus musculus | Inhibition | = | 53 | % | 10.1007/s00044-011-9726-x |
NPT160 | Individual Protein | TAR DNA-binding protein 43 | Homo sapiens | Potency | 25118.9 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 2984.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 21313.8 | nM | PubChem BioAssay data set | ||
NPT104 | Individual Protein | Cerebroside-sulfatase | Homo sapiens | Potency | 151 | nM | PubChem BioAssay data set | |
NPT49 | Individual Protein | DNA-(apurinic or apyrimidinic site) lyase | Homo sapiens | Potency | 0.4 | nM | PubChem BioAssay data set |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC70940 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC274455 |
1.0 | High Similarity | NPC86670 |
0.9643 | High Similarity | NPC322387 |
0.9167 | High Similarity | NPC285773 |
0.908 | High Similarity | NPC329064 |
0.8941 | High Similarity | NPC44830 |
0.881 | High Similarity | NPC127343 |
0.8737 | High Similarity | NPC304873 |
0.8721 | High Similarity | NPC288903 |
0.8602 | High Similarity | NPC261947 |
0.8526 | High Similarity | NPC217621 |
0.8523 | High Similarity | NPC95965 |
0.8523 | High Similarity | NPC294134 |
0.8495 | Intermediate Similarity | NPC172925 |
0.8438 | Intermediate Similarity | NPC128248 |
0.8438 | Intermediate Similarity | NPC136810 |
0.8438 | Intermediate Similarity | NPC225079 |
0.8438 | Intermediate Similarity | NPC133809 |
0.8384 | Intermediate Similarity | NPC37914 |
0.8384 | Intermediate Similarity | NPC94751 |
0.8384 | Intermediate Similarity | NPC142326 |
0.837 | Intermediate Similarity | NPC86987 |
0.8351 | Intermediate Similarity | NPC25458 |
0.8316 | Intermediate Similarity | NPC253423 |
0.83 | Intermediate Similarity | NPC249811 |
0.8295 | Intermediate Similarity | NPC270507 |
0.8283 | Intermediate Similarity | NPC105899 |
0.8265 | Intermediate Similarity | NPC329556 |
0.8247 | Intermediate Similarity | NPC264728 |
0.8229 | Intermediate Similarity | NPC229242 |
0.8202 | Intermediate Similarity | NPC267704 |
0.8182 | Intermediate Similarity | NPC323103 |
0.8182 | Intermediate Similarity | NPC329282 |
0.8182 | Intermediate Similarity | NPC103387 |
0.8172 | Intermediate Similarity | NPC317645 |
0.8172 | Intermediate Similarity | NPC110704 |
0.8155 | Intermediate Similarity | NPC66208 |
0.8152 | Intermediate Similarity | NPC9822 |
0.814 | Intermediate Similarity | NPC103488 |
0.8125 | Intermediate Similarity | NPC477767 |
0.8125 | Intermediate Similarity | NPC226041 |
0.8065 | Intermediate Similarity | NPC84288 |
0.8061 | Intermediate Similarity | NPC473325 |
0.8058 | Intermediate Similarity | NPC475002 |
0.8058 | Intermediate Similarity | NPC95126 |
0.8041 | Intermediate Similarity | NPC120393 |
0.8021 | Intermediate Similarity | NPC469893 |
0.8021 | Intermediate Similarity | NPC61944 |
0.8 | Intermediate Similarity | NPC471721 |
0.7959 | Intermediate Similarity | NPC221825 |
0.7955 | Intermediate Similarity | NPC285716 |
0.7955 | Intermediate Similarity | NPC121800 |
0.7955 | Intermediate Similarity | NPC17408 |
0.7955 | Intermediate Similarity | NPC157055 |
0.7938 | Intermediate Similarity | NPC469891 |
0.7938 | Intermediate Similarity | NPC469890 |
0.7938 | Intermediate Similarity | NPC469892 |
0.7931 | Intermediate Similarity | NPC224544 |
0.7925 | Intermediate Similarity | NPC186933 |
0.7921 | Intermediate Similarity | NPC471186 |
0.79 | Intermediate Similarity | NPC255676 |
0.79 | Intermediate Similarity | NPC247976 |
0.7879 | Intermediate Similarity | NPC469481 |
0.7872 | Intermediate Similarity | NPC62765 |
0.7864 | Intermediate Similarity | NPC318327 |
0.7857 | Intermediate Similarity | NPC271475 |
0.7857 | Intermediate Similarity | NPC160548 |
0.7857 | Intermediate Similarity | NPC175852 |
0.7857 | Intermediate Similarity | NPC210529 |
0.7857 | Intermediate Similarity | NPC155429 |
0.7843 | Intermediate Similarity | NPC83409 |
0.7843 | Intermediate Similarity | NPC244933 |
0.7843 | Intermediate Similarity | NPC185763 |
0.7843 | Intermediate Similarity | NPC85560 |
0.7841 | Intermediate Similarity | NPC170484 |
0.7826 | Intermediate Similarity | NPC474211 |
0.78 | Intermediate Similarity | NPC475978 |
0.78 | Intermediate Similarity | NPC284477 |
0.78 | Intermediate Similarity | NPC474820 |
0.7791 | Intermediate Similarity | NPC189371 |
0.7778 | Intermediate Similarity | NPC7435 |
0.7778 | Intermediate Similarity | NPC230068 |
0.7757 | Intermediate Similarity | NPC221275 |
0.7745 | Intermediate Similarity | NPC172483 |
0.7736 | Intermediate Similarity | NPC93287 |
0.7723 | Intermediate Similarity | NPC160382 |
0.7723 | Intermediate Similarity | NPC274443 |
0.7717 | Intermediate Similarity | NPC474354 |
0.7714 | Intermediate Similarity | NPC474057 |
0.7708 | Intermediate Similarity | NPC323164 |
0.77 | Intermediate Similarity | NPC94487 |
0.77 | Intermediate Similarity | NPC282895 |
0.77 | Intermediate Similarity | NPC52472 |
0.767 | Intermediate Similarity | NPC100767 |
0.766 | Intermediate Similarity | NPC477704 |
0.766 | Intermediate Similarity | NPC477693 |
0.7647 | Intermediate Similarity | NPC19136 |
0.7647 | Intermediate Similarity | NPC472221 |
0.7647 | Intermediate Similarity | NPC472222 |
0.7642 | Intermediate Similarity | NPC292834 |
0.7634 | Intermediate Similarity | NPC93843 |
0.7634 | Intermediate Similarity | NPC318107 |
0.7624 | Intermediate Similarity | NPC222390 |
0.7624 | Intermediate Similarity | NPC244427 |
0.7615 | Intermediate Similarity | NPC212891 |
0.7614 | Intermediate Similarity | NPC298023 |
0.7609 | Intermediate Similarity | NPC168855 |
0.7604 | Intermediate Similarity | NPC141607 |
0.7604 | Intermediate Similarity | NPC187725 |
0.76 | Intermediate Similarity | NPC245561 |
0.76 | Intermediate Similarity | NPC203925 |
0.76 | Intermediate Similarity | NPC476042 |
0.76 | Intermediate Similarity | NPC146351 |
0.76 | Intermediate Similarity | NPC228435 |
0.7596 | Intermediate Similarity | NPC112903 |
0.7593 | Intermediate Similarity | NPC476357 |
0.7579 | Intermediate Similarity | NPC1793 |
0.7579 | Intermediate Similarity | NPC220893 |
0.7573 | Intermediate Similarity | NPC321670 |
0.7558 | Intermediate Similarity | NPC285679 |
0.7551 | Intermediate Similarity | NPC130398 |
0.7549 | Intermediate Similarity | NPC13426 |
0.7545 | Intermediate Similarity | NPC160199 |
0.7545 | Intermediate Similarity | NPC45794 |
0.7527 | Intermediate Similarity | NPC252067 |
0.7525 | Intermediate Similarity | NPC70624 |
0.7524 | Intermediate Similarity | NPC85493 |
0.75 | Intermediate Similarity | NPC109241 |
0.75 | Intermediate Similarity | NPC225060 |
0.75 | Intermediate Similarity | NPC477770 |
0.75 | Intermediate Similarity | NPC78701 |
0.75 | Intermediate Similarity | NPC317280 |
0.75 | Intermediate Similarity | NPC35448 |
0.75 | Intermediate Similarity | NPC153053 |
0.75 | Intermediate Similarity | NPC329387 |
0.7477 | Intermediate Similarity | NPC471188 |
0.7477 | Intermediate Similarity | NPC328694 |
0.7477 | Intermediate Similarity | NPC321852 |
0.7477 | Intermediate Similarity | NPC471189 |
0.7473 | Intermediate Similarity | NPC133050 |
0.7473 | Intermediate Similarity | NPC145053 |
0.7471 | Intermediate Similarity | NPC108218 |
0.7451 | Intermediate Similarity | NPC188895 |
0.7449 | Intermediate Similarity | NPC261181 |
0.7449 | Intermediate Similarity | NPC34243 |
0.7442 | Intermediate Similarity | NPC74458 |
0.7431 | Intermediate Similarity | NPC93181 |
0.7429 | Intermediate Similarity | NPC21929 |
0.7429 | Intermediate Similarity | NPC228737 |
0.7426 | Intermediate Similarity | NPC280869 |
0.7426 | Intermediate Similarity | NPC12730 |
0.7426 | Intermediate Similarity | NPC325497 |
0.7423 | Intermediate Similarity | NPC133461 |
0.7411 | Intermediate Similarity | NPC472708 |
0.7407 | Intermediate Similarity | NPC128368 |
0.7407 | Intermediate Similarity | NPC143768 |
0.7404 | Intermediate Similarity | NPC13495 |
0.74 | Intermediate Similarity | NPC270654 |
0.74 | Intermediate Similarity | NPC249912 |
0.74 | Intermediate Similarity | NPC324569 |
0.74 | Intermediate Similarity | NPC156021 |
0.74 | Intermediate Similarity | NPC276775 |
0.74 | Intermediate Similarity | NPC293628 |
0.74 | Intermediate Similarity | NPC92754 |
0.74 | Intermediate Similarity | NPC289201 |
0.74 | Intermediate Similarity | NPC10781 |
0.74 | Intermediate Similarity | NPC122493 |
0.7396 | Intermediate Similarity | NPC231591 |
0.7383 | Intermediate Similarity | NPC265513 |
0.7383 | Intermediate Similarity | NPC260818 |
0.7374 | Intermediate Similarity | NPC206764 |
0.7368 | Intermediate Similarity | NPC69057 |
0.7368 | Intermediate Similarity | NPC167323 |
0.7368 | Intermediate Similarity | NPC269923 |
0.7368 | Intermediate Similarity | NPC89377 |
0.7368 | Intermediate Similarity | NPC25168 |
0.7364 | Intermediate Similarity | NPC9274 |
0.7363 | Intermediate Similarity | NPC477703 |
0.7363 | Intermediate Similarity | NPC328178 |
0.7363 | Intermediate Similarity | NPC190567 |
0.7358 | Intermediate Similarity | NPC31274 |
0.7347 | Intermediate Similarity | NPC314690 |
0.7347 | Intermediate Similarity | NPC153885 |
0.7345 | Intermediate Similarity | NPC183339 |
0.7345 | Intermediate Similarity | NPC133389 |
0.7345 | Intermediate Similarity | NPC234337 |
0.734 | Intermediate Similarity | NPC475710 |
0.7339 | Intermediate Similarity | NPC294458 |
0.7333 | Intermediate Similarity | NPC50192 |
0.7333 | Intermediate Similarity | NPC317592 |
0.7327 | Intermediate Similarity | NPC260000 |
0.7327 | Intermediate Similarity | NPC145052 |
0.732 | Intermediate Similarity | NPC26224 |
0.732 | Intermediate Similarity | NPC258627 |
0.7315 | Intermediate Similarity | NPC82899 |
0.7315 | Intermediate Similarity | NPC280789 |
0.7315 | Intermediate Similarity | NPC270699 |
0.7312 | Intermediate Similarity | NPC197581 |
0.7308 | Intermediate Similarity | NPC31786 |
0.7297 | Intermediate Similarity | NPC158157 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC70940 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
1.0 | High Similarity | NPD1086 | Approved |
1.0 | High Similarity | NPD1090 | Approved |
1.0 | High Similarity | NPD1089 | Approved |
0.9881 | High Similarity | NPD800 | Approved |
0.9767 | High Similarity | NPD1088 | Approved |
0.9643 | High Similarity | NPD1087 | Approved |
0.9545 | High Similarity | NPD1693 | Approved |
0.9205 | High Similarity | NPD1239 | Approved |
0.9167 | High Similarity | NPD9491 | Approved |
0.913 | High Similarity | NPD2066 | Phase 3 |
0.9121 | High Similarity | NPD1566 | Phase 3 |
0.9121 | High Similarity | NPD1565 | Approved |
0.9121 | High Similarity | NPD1564 | Approved |
0.8791 | High Similarity | NPD1563 | Approved |
0.8764 | High Similarity | NPD5347 | Phase 2 |
0.8764 | High Similarity | NPD5346 | Phase 2 |
0.8706 | High Similarity | NPD226 | Approved |
0.869 | High Similarity | NPD9490 | Approved |
0.8602 | High Similarity | NPD1989 | Approved |
0.8587 | High Similarity | NPD5122 | Clinical (unspecified phase) |
0.8539 | High Similarity | NPD4793 | Discontinued |
0.8495 | Intermediate Similarity | NPD688 | Clinical (unspecified phase) |
0.8353 | Intermediate Similarity | NPD227 | Approved |
0.8353 | Intermediate Similarity | NPD225 | Approved |
0.8265 | Intermediate Similarity | NPD1931 | Clinical (unspecified phase) |
0.8265 | Intermediate Similarity | NPD1929 | Approved |
0.8265 | Intermediate Similarity | NPD1930 | Approved |
0.8261 | Intermediate Similarity | NPD3672 | Approved |
0.8261 | Intermediate Similarity | NPD3673 | Approved |
0.798 | Intermediate Similarity | NPD1932 | Approved |
0.7872 | Intermediate Similarity | NPD9258 | Approved |
0.7872 | Intermediate Similarity | NPD9256 | Approved |
0.7864 | Intermediate Similarity | NPD2329 | Discontinued |
0.7857 | Intermediate Similarity | NPD9495 | Approved |
0.7857 | Intermediate Similarity | NPD253 | Approved |
0.7849 | Intermediate Similarity | NPD1101 | Approved |
0.783 | Intermediate Similarity | NPD1280 | Clinical (unspecified phase) |
0.7788 | Intermediate Similarity | NPD1317 | Discontinued |
0.7757 | Intermediate Similarity | NPD5951 | Approved |
0.7692 | Intermediate Similarity | NPD6831 | Clinical (unspecified phase) |
0.7664 | Intermediate Similarity | NPD2652 | Approved |
0.7664 | Intermediate Similarity | NPD2650 | Approved |
0.7653 | Intermediate Similarity | NPD5206 | Clinical (unspecified phase) |
0.7647 | Intermediate Similarity | NPD5909 | Discontinued |
0.7634 | Intermediate Similarity | NPD9257 | Approved |
0.7634 | Intermediate Similarity | NPD9259 | Approved |
0.76 | Intermediate Similarity | NPD3097 | Clinical (unspecified phase) |
0.7547 | Intermediate Similarity | NPD3643 | Approved |
0.7547 | Intermediate Similarity | NPD3644 | Approved |
0.7547 | Intermediate Similarity | NPD3642 | Approved |
0.7449 | Intermediate Similarity | NPD1409 | Phase 3 |
0.7449 | Intermediate Similarity | NPD1202 | Approved |
0.7449 | Intermediate Similarity | NPD1066 | Discontinued |
0.7431 | Intermediate Similarity | NPD2629 | Approved |
0.7411 | Intermediate Similarity | NPD1245 | Approved |
0.7407 | Intermediate Similarity | NPD1279 | Clinical (unspecified phase) |
0.74 | Intermediate Similarity | NPD9566 | Approved |
0.7383 | Intermediate Similarity | NPD4141 | Clinical (unspecified phase) |
0.7379 | Intermediate Similarity | NPD5738 | Clinical (unspecified phase) |
0.7379 | Intermediate Similarity | NPD6647 | Phase 2 |
0.7379 | Intermediate Similarity | NPD5765 | Approved |
0.7345 | Intermediate Similarity | NPD7163 | Clinical (unspecified phase) |
0.7333 | Intermediate Similarity | NPD6685 | Approved |
0.7308 | Intermediate Similarity | NPD164 | Approved |
0.729 | Intermediate Similarity | NPD1752 | Approved |
0.729 | Intermediate Similarity | NPD4233 | Approved |
0.729 | Intermediate Similarity | NPD4234 | Approved |
0.729 | Intermediate Similarity | NPD1756 | Approved |
0.7273 | Intermediate Similarity | NPD1246 | Approved |
0.7222 | Intermediate Similarity | NPD2181 | Clinical (unspecified phase) |
0.7196 | Intermediate Similarity | NPD2182 | Approved |
0.7193 | Intermediate Similarity | NPD5306 | Approved |
0.7193 | Intermediate Similarity | NPD5305 | Approved |
0.7182 | Intermediate Similarity | NPD1370 | Approved |
0.7182 | Intermediate Similarity | NPD1371 | Approved |
0.7182 | Intermediate Similarity | NPD1374 | Approved |
0.7182 | Intermediate Similarity | NPD1373 | Approved |
0.7172 | Intermediate Similarity | NPD7631 | Approved |
0.7158 | Intermediate Similarity | NPD5734 | Clinical (unspecified phase) |
0.7156 | Intermediate Similarity | NPD9508 | Approved |
0.7143 | Intermediate Similarity | NPD1237 | Approved |
0.713 | Intermediate Similarity | NPD3646 | Clinical (unspecified phase) |
0.713 | Intermediate Similarity | NPD5278 | Discontinued |
0.7128 | Intermediate Similarity | NPD3971 | Phase 1 |
0.7117 | Intermediate Similarity | NPD690 | Clinical (unspecified phase) |
0.7117 | Intermediate Similarity | NPD4766 | Approved |
0.7113 | Intermediate Similarity | NPD531 | Approved |
0.7105 | Intermediate Similarity | NPD5981 | Approved |
0.7105 | Intermediate Similarity | NPD1855 | Clinical (unspecified phase) |
0.7105 | Intermediate Similarity | NPD4105 | Approved |
0.7105 | Intermediate Similarity | NPD4102 | Approved |
0.7091 | Intermediate Similarity | NPD181 | Approved |
0.7091 | Intermediate Similarity | NPD5277 | Phase 2 |
0.7091 | Intermediate Similarity | NPD2607 | Approved |
0.7087 | Intermediate Similarity | NPD1238 | Approved |
0.7087 | Intermediate Similarity | NPD1067 | Discontinued |
0.7075 | Intermediate Similarity | NPD1018 | Approved |
0.7075 | Intermediate Similarity | NPD5048 | Discontinued |
0.7071 | Intermediate Similarity | NPD530 | Approved |
0.7071 | Intermediate Similarity | NPD7609 | Phase 3 |
0.7069 | Intermediate Similarity | NPD4217 | Approved |
0.7069 | Intermediate Similarity | NPD2611 | Approved |
0.7069 | Intermediate Similarity | NPD4216 | Approved |
0.7069 | Intermediate Similarity | NPD3131 | Approved |
0.7069 | Intermediate Similarity | NPD4807 | Approved |
0.7069 | Intermediate Similarity | NPD4215 | Approved |
0.7069 | Intermediate Similarity | NPD4218 | Approved |
0.7069 | Intermediate Similarity | NPD3132 | Approved |
0.7069 | Intermediate Similarity | NPD2609 | Approved |
0.7069 | Intermediate Similarity | NPD2612 | Approved |
0.7069 | Intermediate Similarity | NPD4806 | Approved |
0.7069 | Intermediate Similarity | NPD2608 | Approved |
0.7069 | Intermediate Similarity | NPD2610 | Approved |
0.7064 | Intermediate Similarity | NPD189 | Phase 3 |
0.7064 | Intermediate Similarity | NPD188 | Approved |
0.7059 | Intermediate Similarity | NPD3495 | Discontinued |
0.7043 | Intermediate Similarity | NPD2345 | Approved |
0.7034 | Intermediate Similarity | NPD1283 | Approved |
0.703 | Intermediate Similarity | NPD6048 | Clinical (unspecified phase) |
0.703 | Intermediate Similarity | NPD9260 | Approved |
0.703 | Intermediate Similarity | NPD4814 | Discontinued |
0.703 | Intermediate Similarity | NPD6049 | Phase 2 |
0.7027 | Intermediate Similarity | NPD3598 | Phase 3 |
0.701 | Intermediate Similarity | NPD650 | Approved |
0.7009 | Intermediate Similarity | NPD467 | Phase 1 |
0.7 | Intermediate Similarity | NPD9716 | Approved |
0.6991 | Remote Similarity | NPD4574 | Approved |
0.6991 | Remote Similarity | NPD4576 | Approved |
0.6989 | Remote Similarity | NPD1507 | Clinical (unspecified phase) |
0.6983 | Remote Similarity | NPD4135 | Approved |
0.6983 | Remote Similarity | NPD4106 | Approved |
0.6983 | Remote Similarity | NPD4136 | Approved |
0.6972 | Remote Similarity | NPD2067 | Discontinued |
0.6957 | Remote Similarity | NPD6994 | Approved |
0.6957 | Remote Similarity | NPD6993 | Approved |
0.6949 | Remote Similarity | NPD182 | Clinical (unspecified phase) |
0.6937 | Remote Similarity | NPD6858 | Approved |
0.6937 | Remote Similarity | NPD7094 | Approved |
0.6931 | Remote Similarity | NPD719 | Approved |
0.6931 | Remote Similarity | NPD720 | Approved |
0.6931 | Remote Similarity | NPD845 | Approved |
0.693 | Remote Similarity | NPD7610 | Discontinued |
0.6923 | Remote Similarity | NPD7798 | Approved |
0.6923 | Remote Similarity | NPD5618 | Discontinued |
0.6916 | Remote Similarity | NPD1040 | Phase 2 |
0.6915 | Remote Similarity | NPD942 | Approved |
0.6903 | Remote Similarity | NPD255 | Approved |
0.6903 | Remote Similarity | NPD256 | Approved |
0.6903 | Remote Similarity | NPD4198 | Discontinued |
0.6897 | Remote Similarity | NPD1362 | Clinical (unspecified phase) |
0.6897 | Remote Similarity | NPD4199 | Phase 3 |
0.6893 | Remote Similarity | NPD288 | Approved |
0.6881 | Remote Similarity | NPD476 | Approved |
0.687 | Remote Similarity | NPD4479 | Discontinued |
0.687 | Remote Similarity | NPD7009 | Phase 2 |
0.6864 | Remote Similarity | NPD1608 | Approved |
0.6848 | Remote Similarity | NPD9294 | Approved |
0.6847 | Remote Similarity | NPD6912 | Phase 3 |
0.6842 | Remote Similarity | NPD3797 | Approved |
0.6833 | Remote Similarity | NPD6563 | Approved |
0.6833 | Remote Similarity | NPD6564 | Approved |
0.6833 | Remote Similarity | NPD6565 | Approved |
0.6832 | Remote Similarity | NPD752 | Approved |
0.6796 | Remote Similarity | NPD844 | Approved |
0.6789 | Remote Similarity | NPD9267 | Approved |
0.6789 | Remote Similarity | NPD9265 | Clinical (unspecified phase) |
0.6789 | Remote Similarity | NPD9264 | Approved |
0.6789 | Remote Similarity | NPD9263 | Approved |
0.678 | Remote Similarity | NPD1281 | Approved |
0.6774 | Remote Similarity | NPD7715 | Approved |
0.6774 | Remote Similarity | NPD7714 | Approved |
0.6765 | Remote Similarity | NPD3718 | Approved |
0.6765 | Remote Similarity | NPD3719 | Approved |
0.6762 | Remote Similarity | NPD3020 | Approved |
0.6752 | Remote Similarity | NPD3019 | Approved |
0.6752 | Remote Similarity | NPD2932 | Approved |
0.6748 | Remote Similarity | NPD5952 | Clinical (unspecified phase) |
0.6748 | Remote Similarity | NPD7008 | Discontinued |
0.6729 | Remote Similarity | NPD5700 | Clinical (unspecified phase) |
0.6727 | Remote Similarity | NPD74 | Approved |
0.6727 | Remote Similarity | NPD9266 | Approved |
0.6726 | Remote Similarity | NPD1681 | Approved |
0.6726 | Remote Similarity | NPD6010 | Discontinued |
0.6726 | Remote Similarity | NPD1682 | Approved |
0.6726 | Remote Similarity | NPD1680 | Approved |
0.6724 | Remote Similarity | NPD3798 | Phase 3 |
0.6721 | Remote Similarity | NPD3664 | Approved |
0.6721 | Remote Similarity | NPD3662 | Phase 3 |
0.6721 | Remote Similarity | NPD3661 | Approved |
0.6721 | Remote Similarity | NPD3663 | Approved |
0.6699 | Remote Similarity | NPD1432 | Clinical (unspecified phase) |
0.6698 | Remote Similarity | NPD3135 | Clinical (unspecified phase) |
0.6696 | Remote Similarity | NPD5162 | Approved |
0.6696 | Remote Similarity | NPD9493 | Approved |
0.6696 | Remote Similarity | NPD1609 | Clinical (unspecified phase) |
0.6695 | Remote Similarity | NPD4879 | Approved |
0.6694 | Remote Similarity | NPD2797 | Approved |
0.6667 | Remote Similarity | NPD5240 | Approved |
0.6667 | Remote Similarity | NPD5239 | Approved |
0.6667 | Remote Similarity | NPD9538 | Approved |
Molecular Weight:   | 206.13 |
ALogP:   | 0.9491 |
MLogP:   | 2.67 |
XLogP:   | 5.342 |
# Rotatable Bonds:   | 8 |
Polar Surface Area:   | 37.3 |
# H-Bond Aceptor:   | 2 |
# H-Bond Donor:   | 1 |
# Rings:   | 1 |
# Heavy Atoms:   | 15 |